Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - Other
Ratios

Bristol Myers Squibb (BMYMP) Accumulated Depreciation & Amortization (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Accumulated Depreciation & Amortization for 17 consecutive years, with $4.0 billion as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization fell 58.22% to $4.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.0 billion through Dec 2025, down 58.22% year-over-year, with the annual reading at $4.0 billion for FY2025, 58.22% down from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $4.0 billion at Bristol Myers Squibb, up from $3.0 billion in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $10.7 billion in Q4 2021, with the low at $1.0 billion in Q1 2025.
  • Average Accumulated Depreciation & Amortization over 5 years is $5.6 billion, with a median of $5.1 billion recorded in 2022.
  • The sharpest move saw Accumulated Depreciation & Amortization grew 7.71% in 2021, then crashed 60.7% in 2025.
  • Over 5 years, Accumulated Depreciation & Amortization stood at $10.7 billion in 2021, then dropped by 3.84% to $10.3 billion in 2022, then dropped by 5.02% to $9.8 billion in 2023, then decreased by 1.64% to $9.6 billion in 2024, then plummeted by 58.22% to $4.0 billion in 2025.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $4.0 billion, $3.0 billion, and $2.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.